Bendibel, Rhian Jay D.
HRN: 25-92-77 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/18/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/18/2025
04/25/2025
IV
280 Mg
Q 6 Hours
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes